{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:03:20Z","timestamp":1769025800672,"version":"3.49.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/qai.0b013e3181a324d6","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T12:35:47Z","timestamp":1242909347000},"page":"111-116","source":"Crossref","is-referenced-by-count":55,"title":["Mitochondrial DNA Haplogroups Influence Lipoatrophy After Highly Active Antiretroviral Therapy"],"prefix":"10.1097","volume":"51","author":[{"given":"Sher L","family":"Hendrickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence A","family":"Kingsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Ruiz-Pesini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason C","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa P","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J","family":"Palella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay H","family":"Bream","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas C","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-1-20210131","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/em.20223","article-title":"A brief overview of mechanisms of mitochondrial toxicity from NRTIs.","volume":"48","author":"Kohler","year":"2007","journal-title":"Environ Mol Mutagen"},{"issue":"Suppl 2","key":"R3-1-20210131","doi-asserted-by":"crossref","first-page":"M13","DOI":"10.1177\/135965350501002S03","article-title":"Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.","volume":"10","author":"Lewis","year":"2005","journal-title":"Antivir Ther"},{"key":"R4-1-20210131","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.aids.0000216367.23325.58","article-title":"Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.","volume":"20","author":"Lewis","year":"2006","journal-title":"AIDS"},{"key":"R5-1-20210131","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"R6-1-20210131","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.qai.0000138982.68106.6c","article-title":"Mitochondrial abnormalities in HIV-infected lipoatrophic patients treated with antiretroviral agents.","volume":"37","author":"Chapplain","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-1-20210131","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway.","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"R8-1-20210131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs.","volume":"1","author":"Lewis","year":"1995","journal-title":"Nat Med"},{"key":"R9-1-20210131","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.aids.0000180786.02930.a1","article-title":"Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study.","volume":"19","author":"Hulgan","year":"2005","journal-title":"AIDS"},{"key":"R10-1-20210131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.tpj.6500470","article-title":"The mitochondrial pharmacogenomics of haplogroup T: MTND2*LLHON4917G and antiretroviral therapy-associated peripheral neuropathy.","volume":"8","author":"Canter","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"R11-1-20210131","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1086\/528697","article-title":"Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.","volume":"197","author":"Hulgan","year":"2008","journal-title":"J Infect Dis"},{"key":"R12-1-20210131","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"R13-1-20210131","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","article-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women.","volume":"40","author":"Jacobson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R14-1-20210131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.","volume":"4","author":"Miller","year":"2003","journal-title":"HIV Med"},{"key":"R15-1-20210131","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"R16-1-20210131","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1086\/381684","article-title":"Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study.","volume":"38","author":"Palella","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R17-1-20210131","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/sj.ijo.0803698","article-title":"Lipodystrophy in HIV 1-infected patients: lessons for obesity research.","volume":"31","author":"Villarroya","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"R18-1-20210131","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(07)61027-7","article-title":"Clinical update: adverse effects of antiretroviral therapy.","volume":"370","author":"Calmy","year":"2007","journal-title":"Lancet"},{"key":"R19-1-20210131","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1521\/aeap.14.5.318.23870","article-title":"Secret pills: HIV-positive patients experiences taking antiretroviral therapy in North Carolina.","volume":"14","author":"Golin","year":"2002","journal-title":"AIDS Educ Prev"},{"key":"R20-1-20210131","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/apc.2006.20.359","article-title":"Social stigma concerns and HIV medication adherence.","volume":"20","author":"Rintamaki","year":"2006","journal-title":"AIDS Patient Care STDS"},{"key":"R21-1-20210131","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy.","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"key":"R22-1-20210131","first-page":"246","article-title":"Body habitus changes in HIV-associated lipodystrophy syndrome (HIV-LS). IAPAC sessions 2001, July 18-19, 2001-Chicago.","volume":"7","author":"Kingsley","year":"2001","journal-title":"IAPAC Mon"},{"key":"R23-1-20210131","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/00002030-200110190-00013","article-title":"Elevated blood pressure in subjects with lipodystrophy.","volume":"15","author":"Sattler","year":"2001","journal-title":"AIDS"},{"key":"R24-1-20210131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R25-1-20210131","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1086\/367849","article-title":"Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.","volume":"72","author":"Martin","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R26-1-20210131","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00002030-199911120-00019","article-title":"Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy.","volume":"13","author":"Kakuda","year":"1999","journal-title":"AIDS"},{"key":"R27-1-20210131","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective.","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"R28-1-20210131","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","article-title":"A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.","volume":"39","author":"Wallace","year":"2005","journal-title":"Annu Rev Genet"},{"key":"R29-1-20210131","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1146\/annurev.bi.61.070192.005523","article-title":"Diseases of the mitochondrial DNA.","volume":"61","author":"Wallace","year":"1992","journal-title":"Annu Rev Biochem"},{"key":"R30-1-20210131","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm1096-1065","article-title":"The other human genome: mitochondrial DNA and disease.","volume":"2","author":"Johns","year":"1996","journal-title":"Nat Med"},{"key":"R31-1-20210131","first-page":"492","article-title":"mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases.","volume":"48","author":"Moraes","year":"1991","journal-title":"Am J Hum Genet"},{"key":"R32-1-20210131","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/labinvest.3780288","article-title":"Mitochondrial DNA depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors.","volume":"81","author":"Lewis","year":"2001","journal-title":"Lab Invest"},{"key":"R33-1-20210131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mito.2004.05.008","article-title":"Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies.","volume":"4","author":"McComsey","year":"2004","journal-title":"Mitochondrion"},{"key":"R34-1-20210131","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis.","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"R36-1-20210131","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1088434","article-title":"Effects of purifying and adaptive selection on regional variation in human mtDNA.","volume":"303","author":"Ruiz-Pesini","year":"2004","journal-title":"Science"},{"key":"R37-1-20210131","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0531-5565(02)00266-8","article-title":"mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinsons disease in the Irish.","volume":"38","author":"Ross","year":"2003","journal-title":"Exp Gerontol"},{"key":"R38-1-20210131","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/373937","article-title":"Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.","volume":"72","author":"van der Walt","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R39-1-20210131","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00763096","article-title":"Mitochondrial DNA mutations in diseases of energy metabolism.","volume":"26","author":"Wallace","year":"1994","journal-title":"J Bioenerg Biomembr"},{"key":"R40-1-20210131","first-page":"1107","article-title":"Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484.","volume":"60","author":"Torroni","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R41-1-20210131","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1176\/appi.ajp.157.7.1058","article-title":"Mitochondrial DNA sequence diversity in bipolar affective disorder.","volume":"157","author":"McMahon","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R42-1-20210131","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2004.04.051","article-title":"Analysis of European mitochondrial haplogroups with Alzheimer disease risk.","volume":"365","author":"van der Walt","year":"2004","journal-title":"Neurosci Lett"},{"key":"R43-1-20210131","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/sj.ejhg.5201278","article-title":"Association of the mitochondrial DNA haplogroup J with longevity is population specific.","volume":"12","author":"Dato","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"R44-1-20210131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00439-002-0843-y","article-title":"Mitochondrial DNA polymorphisms associated with longevity in a Finnish population.","volume":"112","author":"Niemi","year":"2003","journal-title":"Hum Genet"},{"key":"R45-1-20210131","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0531-5565(01)00094-8","article-title":"Mitochondrial DNA polymorphism: its role in longevity of the Irish population.","volume":"36","author":"Ross","year":"2001","journal-title":"Exp Gerontol"},{"key":"R46-1-20210131","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/303040","article-title":"Human mtDNA haplogroups associated with high or reduced spermatozoa motility.","volume":"67","author":"Ruiz-Pesini","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R47-1-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.gene.2005.09.015","article-title":"Differences of sperm motility in mitochondrial DNA haplogroup U sublineages.","volume":"368","author":"Montiel-Sosa","year":"2006","journal-title":"Gene"},{"key":"R48-1-20210131","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.ejhg.5201438","article-title":"Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes.","volume":"13","author":"Niemi","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"R49-1-20210131","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/S0140-6736(05)67890-7","article-title":"Mitochondrial DNA and survival after sepsis: a prospective study.","volume":"366","author":"Baudouin","year":"2005","journal-title":"Lancet"},{"key":"R50-1-20210131","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/QAD.0b013e32831940bb","article-title":"Mitochondrial DNA haplogroups influence AIDS progression.","volume":"22","author":"Hendrickson","year":"2008","journal-title":"AIDS"},{"key":"R51-1-20210131","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00126334-199205000-00010","article-title":"Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study.","volume":"5","author":"Phair","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R52-1-20210131","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.2517-6161.1980.tb01109.x","article-title":"Regression models for ordinal data.","volume":"42","author":"Mccullagh","year":"1980","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"R53-1-20210131","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0895-4356(98)00066-3","article-title":"Using binary logistic regression models for ordinal data with non-proportional odds.","volume":"51","author":"Bender","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"R54-1-20210131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0895-4356(96)00312-5","article-title":"Statistical assessment of ordinal outcomes in comparative studies.","volume":"50","author":"Scott","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"R55-1-20210131","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/QAD.0b013e328270356a","article-title":"Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy.","volume":"21","author":"Brown","year":"2007","journal-title":"AIDS"},{"key":"R56-1-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","article-title":"Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients.","volume":"32","author":"Lichtenstein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R57-1-20210131","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/135965350601100205","article-title":"Evaluation of the HIV lipodystrophy case definition in a placebo-controlled, 144-week study in antiretroviral-naive adults.","volume":"11","author":"Law","year":"2006","journal-title":"Antivir Ther"},{"key":"R58-1-20210131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-1293.2007.00421.x","article-title":"Cervical lipomatosis in HIV-infected patients: a case-control study.","volume":"8","author":"Palacios","year":"2007","journal-title":"HIV Med"},{"key":"R59-1-20210131","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01.qai.0000147527.64863.1a","article-title":"Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia.","volume":"38","author":"Mallon","year":"2005","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200906010-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:40:47Z","timestamp":1739119247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200906010-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181a324d6","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}